Doctor's Guide to Medical & Other News


To print: Select File and then Print from your browser's menu
---------------------------------------------------------------------------------------
Title: FDA Approves Tazorac (Tazarotene) Cream for Acne Vulgaris
URL: http://www.pslgroup.com/dg/208D8A.htm
Doctor's Guide
October 16, 2001


IRVINE, CA -- October 16, 2001 -- Allergan today announced it has received approval from the United States Food and Drug Administration (FDA) to market Tazorac® Cream (tazarotene cream 0.1%) for the topical treatment of acne vulgaris.
Tazorac Cream is a topical, receptor-selective retinoid specifically designed to deliver effective retinoid action in both psoriasis and acne. Since 1997, Tazorac Gel (0.05% and 0.1%) has been FDA-approved for the treatment of stable plaque psoriasis and Tazorac Gel 0.1% has also been indicated for mild-to-moderately severe facial acne vulgaris. Tazorac Cream (0.05% and 0.1%) was approved by the FDA for the treatment of plaque psoriasis during the third quarter of 2000.

"This approval provides physicians an effective new prescription alternative for treating a broader range of patients with varied skin types," said F. Michael Ball, Corporate Vice President and President, North America Region. "In addition, the acne indication for Tazorac Cream is an integral part of our strategy to further expand Allergan's skin care pharmaceutical business."

SOURCE: Allergan, Inc.

Related Link: Allergan, Inc.

---------------------------------------------------------------------------------------------
Copyright © 1999 P\S\L Consulting Group Inc. All rights reserved. Republication or redistribution of P\S\L content is expressly prohibited without the prior written consent of P\S\L. P\S\L shall not be liable for any errors, omissions or delays in this content or any other content on its sites, newsletters or other publications, nor for any decisions or actions taken in reliance on such content.
---------------------------------------------------------------------------------------------
This news story was printed from *Doctor's Guide to the Internet*
located at http://www.docguide.com
---------------------------------------------------------------------------------------

Return to News Story Page

This site is maintained by webmaster@pslgroup.com
Please contact us with any comments, problems or bugs.
All contents Copyright (c) 1998 P\S\L Consulting Group Inc.
All rights reserved.